Keywords: |
cancer survival; treatment outcome; disease-free survival; validation process; cancer patient; cancer staging; recurrence risk; lymph node dissection; neoplasm staging; clinical practice; accuracy; reproducibility of results; neoplasm recurrence, local; calibration; risk factors; editorial; age factors; prediction; biopsy; time factors; risk assessment; prostate cancer; prostate-specific antigen; prostatic neoplasms; prostatectomy; models, statistical; prostate biopsy; predictive value of tests; statistical model; model; decision support techniques
|